Vascular Erectile Dysfunction and Subclinical Cardiovascular Disease

Area of Science:

• Cardiology
• Urology
• Preventive Medicine

Background:

• Subclinical cardiovascular disease (CVD) and vascular erectile dysfunction (ED) share common pathophysiological pathways.
• ED is increasingly recognized as an early marker for systemic atherosclerosis.

Purpose of the Study:

• To review the literature on the temporal relationship between subclinical CVD, ED, and clinical CVD.
• To provide a preventive cardiology perspective on evaluating and managing CVD and ED risk.
• To integrate emerging research with expert consensus guidelines like The Princeton Consensus III.

Main Methods:

• Literature review of recent studies on the association between subclinical CVD, ED, and clinical CVD.
• Synthesis of emerging research findings and expert consensus guidelines.
• Application of a preventive cardiology approach to risk assessment and management.

Main Results:

• ED development occurs during the progression from subclinical to clinical CVD.
• Subclinical CVD, assessed by coronary artery calcium (CAC) and carotid plaque, strongly predicts ED.
• ED is an independent risk factor for overt CVD, with symptoms potentially preceding CVD symptoms by 2-3 years.

Conclusions:

• All men with vascular ED warrant cardiovascular risk assessment.
• Coronary artery calcium (CAC) scoring is recommended for advanced risk assessment in intermediate-risk patients (5-20% CVD risk).
• Risk stratification should guide subsequent lifestyle and pharmacologic treatment decisions for CVD and ED.